Viral Hepatitis

You have full text access to this OnlineOpen article

Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up†

  1. Kathleen E. Corey1,3,
  2. Erin Kane3,
  3. Craig Munroe4,
  4. Lydia L. Barlow1,
  5. Hui Zheng2,3,
  6. Raymond T. Chung1,3,‡,*

Article first published online: 10 AUG 2009

DOI: 10.1002/hep.23219

Issue

Hepatology

Hepatology

Volume 50, Issue 4, pages 1030–1037, October 2009

Additional Information

How to Cite

Corey, K. E., Kane, E., Munroe, C., Barlow, L. L., Zheng, H. and Chung, R. T. (2009), Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up. Hepatology, 50: 1030–1037. doi: 10.1002/hep.23219

Author Information

  1. 1

    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA

  2. 2

    MGH Biostatistics Center, Massachusetts General Hospital, Boston, MA

  3. 3

    Harvard Medical School, Boston, MA

  4. 4

    Department of Medicine, Massachusetts General Hospital, Boston, MA

  1. ‡

    fax: 617-643-0446.

*Massachusetts General Hospital, Warren 1007, 55 Fruit Street, Boston, MA 02114

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 28 SEP 2009
  2. Article first published online: 10 AUG 2009
  3. Accepted manuscript online: 10 AUG 2009 12:00AM EST
  4. Manuscript Accepted: 27 APR 2009
  5. Manuscript Received: 10 FEB 2009

Funded by

  • Bristol-Myer-Squibb Virology Fellowship
  • Roche Laboratories
  • Schering-Plough

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (115K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. A. Butt, T. Umbleja, J. W. Andersen, K. E. Sherman, R. T. Chung, Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV-Coinfected Persons: The AIDS Clinical Trials Group A5178 Study, Clinical Infectious Diseases, 2012,

    CrossRef

  2. 2
    P. J. Clark, A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, S. A. Harrison, T. J. Urban, S. Naggie, J. Fellay, H. L. Tillmann, K. Shianna, S. Noviello, L. D. Pedicone, R. Esteban, P. Kwo, M. S. Sulkowski, N. Afdhal, J. K. Albrecht, D. B. Goldstein, J. G. McHutchison, A. J. Muir, Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response, Journal of Viral Hepatitis, 2012, 19, 5
    Direct Link:
  3. 3
    Mario Arciello, Salvatore Petta, Valerio Leoni, Gino Iannucci, Giancarlo Labbadia, Carlo Cammà, Antonio Craxì, Clara Balsano, Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients, Digestive and Liver Disease, 2012, 44, 3, 245

    CrossRef

  4. 4
    Mary A. Rodgers, Valerie A. Villareal, Esperance A. Schaefer, Lee F. Peng, Kathleen E. Corey, Raymond T. Chung, Priscilla L. Yang, Lipid Metabolite Profiling Identifies Desmosterol Metabolism as a New Antiviral Target for Hepatitis C Virus, Journal of the American Chemical Society, 2012, 134, 16, 6896

    CrossRef

  5. 5
    S. Petta, C. Bellia, A. Mazzola, D. Cabibi, C. Cammà, A. Caruso, V. Di Marco, A. Craxì, M. Ciaccio, Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C, Journal of Viral Hepatitis, 2012, 19, 6
    Direct Link:
  6. 6
    Carlo Fabris, Edmondo Falleti, Annarosa Cussigh, Davide Bitetto, Elisabetta Fontanini, Cosimo Colletta, Carmen Vandelli, Sara Cmet, Elisa Ceriani, Carlo Smirne, Pierluigi Toniutto, Mario Pirisi, The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases, Journal of Medical Virology, 2012, 84, 5
    Direct Link:
  7. 7
    K. E. Corey, J. Mendez-Navarro, L. L. Barlow, V. Patwardhan, H. Zheng, A. Y. Kim, G. M. Lauer, R. T. Chung, Acute hepatitis C infection lowers serum lipid levels, Journal of Viral Hepatitis, 2011, 18, 7
    Direct Link:
  8. 8
    Akira Honda, Yasushi Matsuzaki, Cholesterol and chronic hepatitis C virus infection, Hepatology Research, 2011, 41, 8
    Direct Link:
  9. 9
    Vincent Kaddai, Francesco Negro, Current understanding of insulin resistance in hepatitis C, Expert Review of Gastroenterology & Hepatology, 2011, 5, 4, 503

    CrossRef

  10. 10
    C.P.M.S. Oliveira, C.R. Kappel, E.R. Siqueira, V.M.R. Lima, J.T. Stefano, M.T. Michalczuk, S.S. Marini, H.V. Barbeiro, F.G. Soriano, F.J. Carrilho, L.M.M.B. Pereira, M.R. Alvares-da-Silva, Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study, International Journal of Cardiology, 2011,

    CrossRef

  11. 11
    Teruo Miyazaki, Akira Honda, Tadashi Ikegami, Yoshifumi Saitoh, Takeshi Hirayama, Takashi Hara, Mikio Doy, Yasushi Matsuzaki, Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort, Hepatology Research, 2011, 41, 6
    Direct Link:
  12. 12
    G.P. Sorice, G. Muscogiuri, T. Mezza, A. Prioletta, A. Giaccari, Metabolic Syndrome in Transplant Patients: An Academic or a Health Burden?, Transplantation Proceedings, 2011, 43, 1, 313

    CrossRef

  13. 13
    Sanjaya K. Satapathy, Michael R. Charlton, Posttransplant metabolic syndrome: New evidence of an epidemic and recommendations for management , Liver Transplantation, 2011, 17, 1
    Direct Link:
  14. 14
    Yuan-Hung Kuo, Tang-Wei Chuang, Chao-Hung Hung, Chien-Hung Chen, Jing-Houng Wang, Tsung-Hui Hu, Sheng-Nan Lu, Chuan-Mo Lee, Reversal of Hypolipidemia in Chronic Hepatitis C Patients After Successful Antiviral Therapy, Journal of the Formosan Medical Association, 2011, 110, 6, 363

    CrossRef

  15. 15
    Eun Sun Jang, Ji-Eon Won, Jae Il Jung, Sang-Hyub Lee, Jin Wook Kim, Sook-Hyang Jeong, The Effect of Antiviral Therapy on Serum Cholesterol Levels in Chronic Hepatitis C, Gut and Liver, 2011, 5, 3, 356

    CrossRef

  16. 16
    Angelo H. Paredes, Dawn M. Torres, Extrahepatic Manifestations of Hepatitis C Virus Infection: Mixed Cryoglobulinemia and Beyond, Current Hepatitis Reports, 2010, 10, 1, 11

    CrossRef

  17. 17
    Ching-Sheng Hsu, Jia-Horng Kao, Hepatitis C Infection and Metabolic Syndrome, Journal of the Formosan Medical Association, 2010, 109, 6, 403

    CrossRef

  18. 18
    Chia-Chi Wang, Jia-Horng Kao, Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box, Hepatology, 2010, 51, 1
    Direct Link:
  19. 19
    Kymberly D.S. Watt, Michael R. Charlton, Metabolic syndrome and liver transplantation: A review and guide to management, Journal of Hepatology, 2010, 53, 1, 199

    CrossRef

  20. 20
    Christian M. Lange, Michael von Wagner, Jörg Bojunga, Thomas Berg, Harald Farnik, Angela Hassler, Christoph Sarrazin, Eva Herrmann, Stefan Zeuzem, Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin, European Journal of Gastroenterology & Hepatology, 2010, 22, 11, 1303

    CrossRef

  21. 21
    Andrew K. Burroughs, James O'Beirne, Hepatic Transplantation,
    Direct Link:
View Full Article (HTML) Get PDF (115K)